Results 181 to 190 of about 92,853 (340)
Does digoxin decrease morbidity for those in sinus rhythm with heart failure? [PDF]
In patients with congestive heart failure due to systolic dysfunction who are in normal sinus rhythm, digoxin therapy reduces rates of hospitalization, as well as clinical deterioration, defined as worsening New York Heart Association (NYHA ...
Fotinos, Charissa, Nashelsky, Joan
core
Schematic representation of the management pathway in drug‐related advanced atrioventricular block. ABSTRACT The development of advanced atrioventricular block (AVB) in patients on bradycardic and/or antiarrhythmic therapy (drug‐related AVB) represents a clinical challenge, raising the question of whether the AVB is directly caused by these agents ...
Dimitrios Sfairopoulos+7 more
wiley +1 more source
Digoxin induced intestinal vasoconstriction. The effects of proximal arterial stenosis and glucagon administration. [PDF]
Reuven Levinsky+3 more
openalex +1 more source
Individual dosage of digoxin in patients with heart failure [PDF]
Backgroud: After the publication of DIG trial, the therapeutic target of serum digoxin concentration (SDC) for the treatment of heart failure (HF) has been lowered (0.40-1.00 ng/ml).
Brunner-La Rocca, H.+6 more
core
Atrial arrhythmia free survival following catheter ablation according to temporary restoration of sinus rhythm attempt. Abbreviation: TRSR, temporary restoration of sinus rhythm. ABSTRACT Background Long‐standing persistent atrial fibrillation (LSPAF) is associated with adverse atrial structural and electrical remodeling, limiting the success of ...
Mohamad Raad+21 more
wiley +1 more source
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
Eli Muchtar+13 more
semanticscholar +1 more source
Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation. [PDF]
AR Ford+3 more
openalex +1 more source
ABSTRACT Background Benzodiazepine receptor agonists (BZRAs) (benzodiazepines and z‐drugs) may provide limited benefits in the management of insomnia when used short‐term. However, they increase the risk of harms including falls, fractures, hospitalizations, and cognitive impairment. Deprescribing (cessation) of BZRAs may be beneficial for older adults
Aisling M. McEvoy+5 more
wiley +1 more source
A Prospective Analysis of Adverse Drug Reactions in a South Indian Hospital [PDF]
Adverse drug reactions are a great cause of concern to the medical profession, the patients and the pharmaceutical industry. However ADR reporting and monitoring is yet to catch up in India.
Adhikari, P, Padmaja, U, Pereira, P
core
Abstract Objectives Patients with diabetes and Stage 5 chronic kidney disease (CKD) not on dialysis are susceptible to renal replacement therapy and severe complications. Among limited antidiabetic options in this vulnerable population, dipeptidyl peptidase‐4 (DPP‐4) inhibitors (DPP‐4i) are widely used; however, supporting evidence is scant.
Tung‐Ying Hung+6 more
wiley +1 more source